Panel Discussion: ED&I in Precision Medicine: Barriers to Accessibility & Global Technology Accessibility as Biomarker Technologies Become More Complex

Time: 9:20 am
day: Day 1 morning


• While we’re witnessing an exciting period for precision medicine technology innovation, as biomarker investigations become more complex and costly, are new barriers to global precision medicine interventions increasing?
• How can we be more aware of the benefits and challenges associated with growing technology complexity, to create broader awareness and implementation of biomarker strategies globally
• How can we ensure the equitable distribution and access to new technologies equipping physicians with insights to inform more targeted treatment approaches, within and beyond US borders?